The global self-administered parenteral market is poised for substantial growth, with a projected value of USD 25,339.7 million by 2024, according to recent industry analysis. The forecast indicates a robust compound annual growth rate (CAGR) of 4.8% over the coming decade, culminating in a market valuation of USD 40,598.9 million by 2034.
The surge in demand for self-administered parenteral devices is attributed to several key factors driving market growth. These include the increasing prevalence of chronic illnesses, a burgeoning interest in self-injection techniques, and continuous advancements in parenteral device technologies.
Get Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-18779
The rising incidence of chronic diseases globally has heightened the need for efficient and convenient methods of drug delivery, fostering a greater acceptance of self-administered parenteral solutions among patients. Additionally, the growing preference for self-care and patient empowerment has fueled the demand for user-friendly self-injection devices.
Moreover, continuous innovations in parenteral devices, including advancements in needle-free injection systems, smart injectors, and wearable injectors, are expected to further propel market growth over the forecast period.
As the self-administered parenteral market continues to expand, stakeholders across the healthcare sector are poised to capitalize on emerging opportunities and meet the evolving needs of patients worldwide.
Key Takeaways from the Market Study:
- The global market for self-administered parenteral products is projected to attain a valuation of USD 40,598.9 million by 2034.
- By product, the pre-filled syringes held a dominant share value of 8% in 2023.
- By application, pain management segment is projected to advance at 2% CAGR.
- By usage, the disposable segment accounted for a revenue share of 2% in 2023.
- By distribution channel, the hospital pharmacies segment is set to grow at 9% CAGR.
- North America held a global value share of 5% in 2023.
- Demand in India is anticipated to rise at 4% CAGR through 2034.
- China is projected to register a CAGR of 3% between 2024 and 2034.
“Growing prevalence of cardiovascular disorders among aging adults and rising need for advanced drug delivery technologies are expected to spur growth of the self-administered parenteral industry,” opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI).
Request Customization of Report: https://www.futuremarketinsights.com/customization-available/rep-gb-18779
Market Competition:
Top players in the market are focusing on developing new innovative solutions to meet evolving needs and preferences of patients. Similarly, manufacturers like Becton, Dickinson and Company and AstraZeneca are using mergers, acquisitions, and partnerships to enhance their presence in the market and compete with other competitors.
Recent Developments:
- In May 2023, a new autoinjector called UDENYCA AI was launched by Coherus BioSciences, Inc. in the United States.
- In February 2023, AstraZeneca completed the acquisition of CinCor Pharma, Inc. (CinCor).
Key Companies Profiled:
- Becton, Dickinson and Company
- scPharmaceuticals
- Harro Höfliger
- Owen Mumford
- Haselmeier
- Stevanato Group
- Ypsomed AG
- Solteam Group
- AstraZeneca
- Enable Injections
- CCBio
- Phillips-Medisize Corporation
- Sorrel Medical
- Krontec Healthcare
- Subcuject Aps
- Ascendia Pharmaceuticals
- West Pharmaceutical Services, Inc.
A Detailed Full Report: https://www.futuremarketinsights.com/checkout/18779
Key Market Segments Covered in Self-administered Parenteral Industry Research:
By Product:
- Pre-filled Syringes
- Autoinjectors
- Pen Injectors
- Others
By Application:
- Cardiovascular Diseases
- Diabetes
- Osteoporosis
- Pain Management
- Hormone Replacement
- Others
By Usage:
- Disposable
- Reusable
By Distribution Channel:
- Hospital Pharmacies
- Online Pharmacies
- Home Healthcare Providers
- Specialty Clinics
- Others
By Region:
- North America
- Latin America
- East Asia
- South Asia & Pacific
- Western Europe
- Eastern Europe
- Middle East & Africa
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Explore FMI’s related ongoing Coverage on Healthcare Market Insights Domain:
Liquid Filled Capsule Market Demand: The global liquid filled capsule market is expected to rise at a CAGR of 2.9% in the forecast period 2024 to 2034. The market value is projected to increase from USD 1,587.1 million in 2024 to USD 2,113.9 million in 2034.
Inhalation CDMO Market Growth: The global inhalation CDMO industry is expected to expand at a CAGR of 6.4% in the forecast period 2024 to 2034. The market value is projected to increase from USD 2,018.0 million in 2024 to USD 3,740.2 million in 2034.
Nutraceutical CDMO Market Outlook: The global nutraceutical CDMO market size is projected to expand with a CAGR of 5.6% during the assessment period. The market value is expected to increase from USD 35,730.8 million in 2024 to USD 61,655.3 million by 2034.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
